[en] Preserving fertility is essential when managing benign gynecologic disorders in reproductive-aged women. Surgical interventions can impact future fertility, therefore requiring an evidence-based, individualized approach. The FIGO Committee on Reproductive Endocrinology and Infertility reviewed current literature to develop recommendations for fertility-sparing surgical management. Effective treatment must balance disease control with fertility preservation. Evidence supports refined surgical techniques and alternative methods that minimize reproductive harm. In pregnancy loss management, medical treatment is preferred; however, if surgery is needed, hysteroscopic evacuation is safer than sharp curettage, reducing the risk of intrauterine adhesions. Similarly for other operative hysteroscopic procedures or abdominal procedures, including myomectomy, the use of an adhesion-reducing substance is recommended. During abdominal myomectomy, only symptomatic or fertility-impairing fibroids should be removed, as excessive resection may reduce pregnancy chances. In endometrioma surgery, preserving ovarian tissue is crucial by minimizing stripping of the pseudocapsule, or using sclerotherapy may help. Oocyte cryopreservation should be discussed when recurrence or reduced ovarian reserve is a concern. Hydrosalpinx often requires salpingectomy to enhance in vitro fertilization outcomes, but surgeons should protect ovarian blood flow by minimizing thermal injury. For adenomyosis, medical management is preferred due to the risks associated with surgical techniques like the triple-flap procedure. In polycystic ovary syndrome, laparoscopic ovarian drilling is discouraged; ovulation induction with letrozole or gonadotropins is safer and effective. In summary, fertility-sparing treatment demands personalized, evidence-based strategies that prioritize reproductive potential while managing disease. As reproductive goals evolve, continued refinement of these approaches remains vital to women's health care.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Tulandi, Togas ; Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada
Mocanu, Edgar; Rotunda Hospital, Dublin, Ireland ; Royal College of Surgeons in Ireland, Dublin, Ireland
Purandare, Nikhil; Department of Obstetrics and Gynaecology, Galway University Hospital, Galway, Ireland
Nelson, Scott M; School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK
Barnea, Eytan R; University of Miami Miller School of Medicine, New York, New York, USA
Dolmo Carluccio, Ruth; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA
Topcu, Elif Goknur; Sisli Kolan International Hospital, Istanbul, Turkey
Feldberg, Dov; Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel ; Tel Aviv University School of Medicine, Tel Aviv, Israel
FIGO Committee on Reproductive Endocrinology and Infertility
Other collaborator :
Henry, Laurie ; Université de Liège - ULiège > Département des sciences cliniques ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gynécologie-obstétrique (CHR)
Language :
English
Title :
Gynecologic surgery for benign disease: Preserving reproductive potential.
Publication date :
24 September 2025
Journal title :
International Journal of Gynecology and Obstetrics
UpToDate. https://www.uptodate.com. Accessed July 7, 2025.
Hooker AB, de Leeuw RA, Twisk JWR, Brolmann HAM, Huirne JAF. Reproductive performance of women with and without intrauterine adhesions following recurrent dilatation and curettage for pregnancy loss: long-term follow-up of a randomized controlled trial. Hum Reprod. 2021;36:70-81.
Sroussi J, Bourret A, Pourcelot AG, et al. Does hyaluronic acid gel reduce intrauterine adhesions after dilation and curettage in women with pregnancy loss? A multicentric randomized controlled trial (HYFACO study). Am J Obstet Gynecol. 2022;227:597.e1-597.e8.
Wagenaar LP, Hamerlynck TW, Radder CM, et al. Hysteroscopic morcellation vs. curettage for removal of retained products of conception: a multicenter randomized controlled trial. Fertil Steril. 2023;120:1243-1251.
Gilman Barber AR, Rhone SA, Fluker MR. Curettage and Asherman's syndrome-lessons to (re-) learn? J Obstet Gynaecol Can. 2014;36(11):997-1001.
World Health Organization. Abortion care guideline. WHO; 2022. https://www.who.int/publications/i/item/9789240039483. Accessed September 2025.
Villegas-Echeverri JD, Pope R, Robert M, et al. FIGO-GCH joint consensus statement on the current status and recommendations for the use of blind intrauterine procedures in the evaluation and management of women with suspected intrauterine pathologies. Int J Gynecol Obstet. 2025;168:493-496.
Ciavattini A, Clemente N, Delli Carpini G, et al. Loop electrosurgical excision procedure and risk of pregnancy loss. Fertil Steril. 2015;103:1043.
Bjørge T, Skare GB, Bjørge L, Tropé A, Lönnberg S. Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia. Obstet Gynecol. 2016;128:1265-1273.
Heinonen A, Gissler M, Riska A, Paavonen J, Tapper AM, Jakobsson M. Loop electrosurgical excision procedure and the risk for preterm delivery. Obstet Gynecol. 2013;121:1063-1068.
Maina G, Ribaldone R, Danese S, et al. Obstetric outcomes in patients who have undergone excisional treatment for high-grade cervical squamous intra-epithelial neoplasia. Eur J Obstet Gynecol Reprod Biol. 2019;236:210-213.
Jakobsson M, Norwitz ER. Reproductive effects of cervical excisional and ablative procedures. In: UpToDate.
Mossa MA, Carter PG, Abdu S, Young MP, Thomas VA, Barton DP. Comparative study of two methods of large loop excision of the transformation zone. BJOG. 2005;112(4):490-494.
Lin YN, Hwang JL, Huang LW, et al. Efficacy of hysteroscopic cervical resection for cervical stenosis. J Minim Invasive Gynecol. 2013;20(6):836-841.
Takasaki K, Henmi H, Ikeda U, Endo T, Azumaguchi A, Nagasaka K. Intrauterine adhesion after hysteroscopic myomectomy of submucous myomas. J Obstet Gynaecol Res. 2023;49:675-681.
Shue S, Radeva M, Falcone T. Comparison of long-term fertility outcomes after myomectomy: relationship with number of myomas removed. J Minim Invasive Gynecol. 2018;25:1002-1008.
Cubo-Abert M, Simó-González M, Haimovich S, et al. The importance of the pseudocapsule in the management of uterine myoma: state of the art and expert recommendations. Int J Gynecol Obstet. 2025; [Online ahead of print].
Kathopoulis N, Prodromidou A, Douligeris A, et al. Barbed sutures compared with conventional sutures during laparoscopic myomectomy: a systematic review and meta-analysis. Obstet Gynecol. 2024;144:e81-e100.
Cohen A, Tulandi T. Long-term sequelae of unconfined morcellation during laparoscopic gynecological surgery. Maturitas. 2017;97:1-5.
Amer SA, El Shamy TT, James C, Yosef AH, Mohamed AA. The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: a meta-analysis. Reproduction. 2017;154:R13-R21.
Younis JS, Shapso N, Ben-Sira Y, Nelson SM, Izhaki I. Endometrioma surgery-a systematic review and meta-analysis of the effect on antral follicle count and anti-Müllerian hormone. Am J Obstet Gynecol. 2022;226:33-51.e7.
Crestani A, Merlot B, Dennis T, Chanavaz-Lacheray I, Roman H. Impact of laparoscopic sclerotherapy for ovarian endometriomas on ovarian reserve. J Minim Invasive Gynecol. 2023;30:32-38.
Capmas P, Suarthana E, Tulandi T. Management of Hydrosalpinx in the era of assisted reproductive technology: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28:418-441.
Fan M, Ma L. Effect of salpingectomy on ovarian response to hyperstimulation during in vitro fertilization: a meta-analysis. Fertil Steril. 2016;106:322-329.e9.
Almog B, Wagman I, Bibi G, et al. Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal. Fertil Steril. 2011;95:2474-2476.
Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril. 2017;108:483-490.e3.
Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril. 2018;109:406-417.
Ichinose M, Iriyama T, Hiraike O, et al. Hysteroscopic endometrial defect following Adenomyomectomy and incidence of placenta Accreta Spectrum and uterine rupture complications for subsequent pregnancy. Reprod Sci. 2025;32:467-473.
Pecorella G, Nigdelis MP, Sparic R, Morciano A, Tinelli A. Adenomyosis and fertility-sparing surgery: a literature appraisal. Int J Gynecol Obstet. 2024;166:512-526.
Felemban A, Lin TS, Tulandi T. Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal. Fertil Steril. 2000;73:266-269.
Pirwany I, Tulandi T. Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure? Fertil Steril. 2003;80:241-251.
Yu Q, Hu S, Wang Y, Cheng G, Xia W, Zhu C. Letrozole versus laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2019;17:17.